Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 13.7963 | 100 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 13.7092 | 100 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 13.7524 | 100 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 13.8905 | 100 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 13.6856 | 100 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 13.5454 | 100 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 13.4184 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 13.5296 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 13.4412 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.7531 | 100 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 13.7983 | 100 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.6866 | 100 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.9083 | 100 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.7087 | 100 |